Dmca Compliance Sample Clauses

Dmca Compliance. The Digital Millennium Copyright Act (“DMCA”) requires thatB The Broker take certain measures to respond to those claiming their copyright(s) has been infringed with content posted on the Website. If B The Broker receives a DMCA takedown request for content provided by Advertiser, B The Broker will gather from the complainant all information required by 17 U.S.C. § 512(c)(3). If Advertiser believes thatthe copyright content proposed to be removed (or to which access is requested to be disabled) is not infringing, or that Advertiser has the authorization from the copyright owner, the copyright owner's agent, or pursuant to the law, to post and use the materialin the content posted, Advertiser may send a written counter-notice containing the following information to xxxxxxx@xxxxxxxxxx.xxx with the following information: (1) Advertiser’s physical or electronic signature; (2) identification of the content that hasbeen reported, and the location at which the content appears; (3) a statement that Advertiser a good faith belief that the content is not infringing upon the complainant’scopyright, or that Advertiser has permission to use such content; and (4) Advertiser’s name, address, telephone number, and email address, and a statement that Advertiserconsents to the jurisdiction of the 4th Judicial District Court in Boise, Idaho; and (5) a statement that Advertiser will accept service of process from the person who provided notification of the alleged infringement.
AutoNDA by SimpleDocs
Dmca Compliance. ZapIT! Medical respects the intellectual property rights of others, and we prohibit users of our website from submitting, uploading, posting or otherwise transmitting any materials that violate another person’s intellectual property rights. ZapIT! Medical complies with the provisions of the Digital Millennium Copyright Act (“DMCA”). Additionally, it is our policy to terminate usage rights and any applicable user accounts of users we determine to be “repeat infringers” of others’ copyrights. Content hosted on Third Party Websites is the responsibility of those Websites, and not of ZapIT! Medical, regardless of whether the Content bears a ZapIT! Medical license. If you are the copyright owner of Content hosted on a Third Party Website, and you have not authorized the use of your Content, please contact the administrator of the hosting Website directly to have the Content removed.
Dmca Compliance. Georgetown complies with the provisions of the Digital Millennium Copyright Act (“DMCA”). Contact Georgetown’s DMCA designated agent to report alleged copyright infringement on G-DOC through completing the information contained on the following link: xxxx://xxxxxxx.xxxxxxxxxx.xxx/index.cfm?Action=Mail&NetID=niderhp
Dmca Compliance. The Company uses the copyright infringement procedures of the Digital Millennium Copyright Act (“DMCA”).
Dmca Compliance. The Company and the Subsidiaries of the Company have posted on the websites of the Company, the Subsidiaries of the Company and their Affiliates the acceptable use policy of the Company and the Subsidiaries of the Company and such policy includes the name and contact information of a copyright agent and any other information required by the U.S. Digital Millennium Copyright Act, 17 U.S.C. § 512 et seq. (“DMCA”). Each of the Company, the Subsidiaries of the Company and their Affiliates operates and has operated its business in a manner that would afford each of the Company, the Subsidiaries of the Company and their Affiliates the benefits of the “safe harbors” of the DMCA and the Communications Decency Act, 47 U.S.C. §§ 230(c)(1) and 230(c)(2). Each of the Company, the Subsidiaries of the Company and their Affiliates has adopted and complied with a policy of removing content that is the subject of a DMCA take-down notification unless the poster serves a counter notification in a timely manner.
Dmca Compliance. The Company conducts and has conducted the Business in such a manner as to take reasonable advantage, if and when applicable, of the safe harbors provided by Section 512 of the Digital Millennium Copyright Act (the “DMCA”) and by any substantially similar Applicable Law in any other jurisdiction in which Company conducts the Business, including by informing users of its products and services of such policy, designating an agent for notice of infringement claims, registering such agent with the United States Copyright Office, and taking appropriate action expeditiously upon receiving notice of possible infringement in accordance with the “notice and take down” procedure of the DMCA or such other Applicable Law.
Dmca Compliance. Company has complied in all material respects with all requirements under applicable law to qualify for a limitation on Liability for copyright infringement, including without limitation (i) having no actual Knowledge that any material or an activity using the material on the Company Websites is infringing; (ii) having no awareness of facts or circumstances from which infringing activity is apparent to Buyer; (iii) upon obtaining actual knowledge that material or an activity using the material on the Company Websites is infringing, acting expeditiously to remove or disable access to any infringing material, and (iv) upon receiving notification of claimed infringement, responding expeditiously to remove or disable access to material that is claimed to be infringing or to be the subject of infringing activity.
AutoNDA by SimpleDocs
Dmca Compliance. We respect the intellectual property of others, and We ask Our customers to do the same. If you believe that your work has been copied in a way that constitutes copyright infringement, please provide Our Designated Copyright Agent with the following information:
Dmca Compliance 

Related to Dmca Compliance

  • FCPA Compliance The Company has not and, to the Company’s actual knowledge, none of its employees or agents at any time during the last five years have (i) made any unlawful contribution to any candidate for foreign office, or failed to disclose fully any contribution in violation of law, or (ii) made any payment to any federal or state governmental officer or official, or other person charged with similar public or quasi-public duties, other than payments required or permitted by the laws of the United States or any jurisdiction thereof.

  • CRA Compliance Neither Seller nor any Seller Subsidiary has received any notice of non-compliance with the applicable provisions of the CRA and the regulations promulgated thereunder. As of the date hereof, Seller Sub’s most recent examination rating under the CRA was “satisfactory” or better. Seller knows of no fact or circumstance or set of facts or circumstances which would be reasonably likely to cause Seller or any Seller Subsidiary to receive any notice of non-compliance with such provisions of the CRA or cause the CRA rating of Seller or any Seller Subsidiary to decrease below the “satisfactory” level.

  • HIPAA Compliance If this Contract involves services, activities or products subject to the Health Insurance Portability and Accountability Act of 1996 (HIPAA), the Contractor covenants that it will appropriately safeguard Protected Health Information (defined in 45 CFR 160.103), and agrees that it is subject to, and shall comply with, the provisions of 45 CFR 164 Subpart E regarding use and disclosure of Protected Health Information.

  • ISRA Compliance (a) Tenant shall, at Tenant’s own expense, comply with the Industrial Site Recovery Act, N.J.

  • ADA Compliance A. The Americans with Disabilities Act (42 U.S.C. § 12101, et seq.) and the regulations thereunder (28 C.F.R. § 35.130) (“ADA”) prohibit discrimination against persons with disabilities by the State, whether directly or through contractual arrangements, in the provision of any aid, benefit, or service. As a condition of receiving this Agreement, the Company certifies that services, programs, and activities provided under this Agreement are and will continue to be in compliance with the ADA.

  • FDA Compliance The Company: (A) is and at all times has been in material compliance with all statutes, rules or regulations of the FDA and other comparable governmental entities applicable to the ownership, testing, development, manufacture, packaging, processing, use, distribution, marketing, labeling, promotion, sale, offer for sale, storage, import, export or disposal of any product under development, manufactured or distributed by the Company (“Applicable Laws”); (B) has not received any FDA Form 483, notice of adverse finding, warning letter, untitled letter or other correspondence or notice from the FDA or any governmental entity alleging or asserting material noncompliance with any Applicable Laws or any licenses, certificates, approvals, clearances, exemptions, authorizations, permits and supplements or amendments thereto required by any such Applicable Laws (“Authorizations”); (C) possesses all material Authorizations and such Authorizations are valid and in full force and effect and the Company is not in material violation of any term of any such Authorizations; (D) has not received notice of any claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action from the FDA or any governmental entity or third party alleging that any product operation or activity is in material violation of any Applicable Laws or Authorizations and has no knowledge that the FDA or any governmental entity or third party is considering any such claim, litigation, arbitration, action, suit, investigation or proceeding; (E) has not received notice that the FDA or any governmental entity has taken, is taking or intends to take action to limit, suspend, modify or revoke any material Authorizations and has no knowledge that the FDA or any governmental entity is considering such action; and (F) has filed, obtained, maintained or submitted all material reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments as required by any Applicable Laws or Authorizations and that all such reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments were materially complete and correct on the date filed (or were corrected or supplemented by a subsequent submission).

  • Y2K Compliance PFPC further represents and warrants that any and all electronic data processing systems and programs that it uses or retains in connection with the provision of services hereunder on or before January 1, 1999 will be year 2000 compliant.

  • AML Compliance The Dealer Manager represents to the Company that it has established and implemented anti-money laundering compliance programs in accordance with applicable law, including applicable FINRA Conduct Rules, Exchange Act Regulations and the USA PATRIOT Act, specifically including, but not limited to, Section 352 of the International Money Laundering Abatement and Anti-Terrorist Financing Act of 2001 (the “Money Laundering Abatement Act,” and together with the USA PATRIOT Act, the “AML Rules”) reasonably expected to detect and cause the reporting of suspicious transactions in connection with the offering and sale of the Offered Shares. The Dealer Manager further represents that it is currently in compliance with all AML Rules, specifically including, but not limited to, the Customer Identification Program requirements under Section 326 of the Money Laundering Abatement Act, and the Dealer Manager hereby covenants to remain in compliance with such requirements and shall, upon request by the Company, provide a certification to the Company that, as of the date of such certification (a) its AML Program is consistent with the AML Rules and (b) it is currently in compliance with all AML Rules, specifically including, but not limited to, the Customer Identification Program requirements under Section 326 of the Money Laundering Abatement Act.

  • SOX Compliance The Company has taken all actions it deems reasonably necessary or advisable to take on or prior to the date of this Agreement to assure that, upon and at all times after the Effective Date, it will be in compliance in all material respects with all applicable provisions of the Sxxxxxxx-Xxxxx Act of 2002 and all rules and regulations promulgated thereunder or implementing the provisions thereof. (the “Sxxxxxxx-Xxxxx Act”) that are then in effect and will take all action it deems reasonably necessary or advisable to assure that it will be in compliance in all material respects with other applicable provisions of the Sxxxxxxx-Xxxxx Act not currently in effect upon it and at all times after the effectiveness of such provisions.

  • FINRA Compliance You represent and warrant that you are (a) a broker or dealer (as defined in Section 3(a)(4) or 3(a)(5) of the 0000 Xxx) that is a member in good standing of FINRA, (b) a non-U.S. bank, broker, dealer or other non-U.S. institution that is not eligible for membership in FINRA and is not required to be registered as a broker or dealer under the 1934 Act (a “non-member non-U.S. dealer”), or (c) only in the case of Offerings of Securities that are exempted securities (as defined in Section 3(a)(12) of the 1934 Act), and such other Securities as from time to time may be sold by a “bank” (as defined in Section 3(a)(6) of the 1934 Act (a “Bank”)), that you are a Bank that is acting in connection with the Offering in accordance with an applicable exception or exemption from the definitions of broker and dealer under Sections 3(a)(4) and 3(a)(5) of the 1934 Act. You further represent, warrant and agree that, in connection with any purchase or sale of the Securities wherein a selling concession, discount or other allowance is received or granted by or to you:

Time is Money Join Law Insider Premium to draft better contracts faster.